Sofinnova Investments, Inc. Aligos Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.06 Billion
- Q3 2024
Shares
6 transactions
Others Institutions Holding ALGS
# of Institutions
1Shares Held
227KCall Options Held
0Put Options Held
0About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $1.57B
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...